Mechanisms of airway hypersecretion and novel therapy

Chest

Volumn 117, Issue 5 SUPPL. 1, 2000, Pages 262S-266S

  Nadel, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Airway hypersecretion; Epidermal growth factor activation; Goblet cell metaplasia

Indexed keywords

ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; BRONCHUS SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; FORCED EXPIRATORY VOLUME; GOBLET CELL; MORTALITY; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034118972     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.5_suppl_1.262S-a     Document Type: Conference Paper

References (17)

1. Snider GL, Faling LJ, Rennard SI. Chronic bronchitis and emphysema. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. 2nd ed. New York, NY: Saunders, 1994; 1331-1397
2. Boat TF, Boucher RC. Cystic fibrosis. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. 2nd ed. New York, NY: Saunders, 1994; 1418-1450
3. Fahy JV, Schuster A, Ueki I, et al. Mucus hypersecretion in bronchiectasis: the role of neutrophil proteases. Am Rev Respir Dis 1992; 146:1430-1433
4. Shimura S, Andoh Y, Haraguchi M, et al. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996; 9:1395-1401
5. Speizer FE, Fay ME, Dockery DW, et al. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989; 140:549-555
6. Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45:8:579-585
7. Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? Am Rev Respir Dis 1986; 134:688-693
8. Takeyama K, Dabbagh K, Lee H-M, et al. Epidermal growth factor system regulates mucin production in airways. Proc Nati Acad Sci USA 1999; 96:3081-3086
9. Ruocco S, Lallemand A, Tournier JM, et al. Expression and localization of epidermal growth factor, transforming growth factor-alpha, and localization of their common receptor in fetal human lung development. Pediatr Res 1996; 39:448-455
10. Amishima M, Munakata M, Nasuhara Y, et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Crit Care Med 1998; 157:1907-1912
11. Ulich TR. In: Kelley J, ed. Cytokines of the lung. New York, NY: Dekker, 1993; 307-332
12. Lou Y-P, Takeyama K, Grattan K, et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. Am J Respir Grit Care Med 1998; 157:1927-1934
13. Mercer RR, Russel ML, Roggli VL, et al. Cell number and distribution in human and rat airways. Am J Respir Cell Mol Biol 1994; 10:613-624
14. Takeyama K, Agustí C, Ueki I, et al. Neutrophil-dependent goblet cell degranulation: role of membrane-bound elastase and adhesion molecules. Am J Physiol 1998; 275 (Lung Cell Mol Physiol 19):L294-L302
15. Harkema JR, Hotchkiss JA. Ozone-and endotoxin-induced mucous cell metaplasias in rat airway epithelium: novel animal models to study toxicant-induced epithelial transformation in airways. Toxicol Lett 1993; 68:251-263
16. Jany B, Gallup M, Tsuda T, et al. Mucin gene expression in rat airways following infection and irritation. Biochem Biophys Res Commun 1991; 181:1-8
17. Shimizu T, Takahashi Y, Kawaguchi S, et al. Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin. Am J Respir Grit Care Med 1996; 153:1412-1418